Pressure Ulcer Diagnostics Market Trends, 2021-2031

Pressure Ulcer Diagnostics Market (Diagnostic Test: Imaging Technique, Microbiological Tests, and Others; Wound: Stage 1, Stage 2, Stage 3, and Stage 4; and End-user: Hospitals, Nursing Homes, Homecare Settings, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Prevention Strategies Gain Importance During Coronavirus Pandemic

Given the importance of pressure ulcer (PU) prevention in patients during the coronavirus pandemic, stakeholders in the pressure ulcer diagnostics market are gaining awareness about focused prevention strategies involving skin assessment and care. In order to achieve this, stakeholders and healthcare providers are increasing the availability of diagnostic tests such as magnetic resonance imaging (MRI) and computed tomography (CT) scan, among others.

Since stakeholders in the pressure ulcer diagnostics market are under scrutiny similar to the entire healthcare sector, stakeholders are encouraging healthcare providers to adopt prevention strategies including offloading and pressure redistribution to improve the patient quality of life. Healthcare providers are maintaining sufficient inventories for dressing and other therapeutics to reduce the incidence and prevalence of largely preventable wounds.

pressure ulcer diagnostics market infographic

Progression of BP May Lead to Challenges in Accurate Diagnosis

The pressure ulcer diagnostics market is projected to cross US$ 1.49 Bn by 2031. Bullous pemphigoid (BP) is a severe skin disorder with high morbidity and mortality rates. However, as the condition progresses, rendering an accurate diagnosis may be a challenge for clinicians. Hence, practitioners are arriving at a diagnosis of BP by evaluating the clinical manifestations of the disorder and by obtaining a detailed patient history.

In order to improve patient outcomes, healthcare providers are conducting clinical evaluation of a pressure ulcer based on quantitative and qualitative evaluation. The acetate tracing is emerging as the gold standard for measuring wound surface area.

mHealth Apps Proving Advantageous in Digital Wound Measurement

Mobile health (mHealth) apps are being publicized as a new business model in the pressure ulcer diagnostics market. Since acetate tracing is associated with difficulties in material availability, data storage issues, and the time needed to calculate the surface area, stakeholders and startups are bullish on expanding their medical services through mHealth apps.

mHealth apps are storming the pressure ulcer diagnostics market. These apps help use planimetry techniques that are a promising alternative to traditional wound assessment methods. Thus, to maximize the use of mHealth apps, market stakeholders must increase R&D to conduct studies on larger and more diverse wounds. The imitoMeasure is gaining popularity for digital wound measurement.

Treatment of Underlying Diseases Helps Improve Patient Outcomes

Despite awareness about the issues associated with pressure ulcers, the rates of pressure wounds remain high in long-term care facilities and nursing homes, where there is a lack of staff and optimal care is not always possible. In order to prevent decubitus ulcers, healthcare providers are creating awareness about the proper placement of patients in bed and treatment of underlying diseases.

CT is the modality of choice for assessment of bone involvement in pressure ulcers. Companies in the pressure ulcer diagnostics market are increasing their focus in CT fistulography with contrast introduction in the fistula in order to show contrast diffusion in the fistulous tract, thus allowing the evaluation of necrosis extension to the joints or bone surface.

pressure ulcer diagnostics market segmentation

Analysts’ Viewpoint

Besides advanced services through MRI and CT, healthcare providers should maintain inventories for pH-balanced cleansers, dressings such as hydrocolloids, and positioning devices to improve the patient quality of life amid the COVID-19 pandemic. Pain and discomfort are being controlled with the help of analgesics. Although acetate tracing is the standard technique used to measure wound surface, using it in daily practice is linked with challenges in data storage issues, material availability, and the time needed to calculate the surface area. Hence, companies in the pressure ulcer diagnostics market should unlock value-grab opportunities in mHealth apps that help in implementing planimetry techniques.

Pressure Ulcer Diagnostics Market: Overview

  • The global pressure ulcer diagnostics market was valued at US$ 880.50 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031
  • Launch of innovative pressure ulcer diagnostic products, presence of key players, rise in awareness about pressure ulcer diagnostic tools & tests, and surge in COVID-19 patients suffering from pressure ulcers & other chronic diseases are anticipated to boost the growth of the global pressure ulcer diagnostics market during the forecast period
  • Pressure ulcer, also known as bed sore, pressure sore, or decubitus ulcer, is skin and tissue injury resulting from the pressure on the skin for prolonged time. Pressure ulcers are located on the skin covering heels, ankles, hips, tailbone, and other bony areas. Bedsores are likely to develop within hours or days, which should be treated at the earliest. Few bedsores take time to heal, and therefore require prevention. The different types of pressure ulcers are stage 1, stage 2, stage 3, and stage 4. Healing takes time if the wound has progressed to final stage. Hence, various diagnostic tools are available for the early detection of pressure ulcers.
  • Rise in number of patients suffering from pressure ulcers and increase in admission of patients in ICU settings, nursing homes, and long-term care settings amid the COVID-19 pandemic are anticipated to fuel the growth of the global pressure ulcer diagnostics market

Pressure Ulcer Diagnostics Market: Segmentation

  • The global pressure ulcer diagnostics market has been segmented based on diagnostic test, wound, end-user, and region
  • In terms of diagnostic test, the global pressure ulcer diagnostics market has been classified into imaging techniques, microbiological tests, and others. The imaging technique segment has been segregated into magnetic resonance imaging (MRI), computed tomography (CT) scan, fluorescence imaging, ultrasound imaging, and others. The imaging technique segment accounted for major market share in 2020, as MRI systems are widely considered technology for diagnosis of pressure ulcer and adoption of standard imaging methods such as computed tomography, fluorescence imaging, and other advanced technology for early diagnosis of pressure ulcers.
  • Based on wound, the global pressure ulcer diagnostics market has been bifurcated into stage 1, stage 2, stage 3, and stage 4. The stage 1 segment held the largest market share in 2020, owing to higher prevalence of stage 1 pressure ulcer in ICU admitted and elderly patients. Moreover, increase in admissions of critical patients in hospital intensive care units is expected to propel the segment during the forecast period.
  • In terms of end-user, the global pressure ulcer diagnostics market has been divided into hospitals, homecare settings, nursing homes, and others. The hospitals segment accounted for the largest market share in 2020, ascribed to surge in prevalence of pressure ulcers among patients in ICU. According to research, the prevalence of hospital-acquired pressure injuries is expected to be 8.5% in adult patients.

Pressure Ulcer Diagnostics Market: Regional Segmentation

  • In terms of region, the global pressure ulcer diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global pressure ulcer diagnostics market in 2020. Growth of the market in the region can be attributed to rise in prevalence of pressure ulcers in the U.S., higher expenditure on the management of pressure ulcers, which is estimated US$ 11 Bn every year, surge in hospital-acquired pressure ulcers, and rise in admission of elderly patients with pressure ulcer. According to research, 2.5 million people in the U.S. develop pressure ulcers every year, which is expected to boost the need of pressure ulcer diagnostic tools. Moreover, availability of innovative diagnostic tools, rise in awareness about pressure ulcer scanning devices, and presence of prominent players are projected to boost the growth of the pressure ulcer diagnostics market in North America during the forecast period.
  • The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period. Rise in prevalence of diseases leading to chronic bedsores, increase in number of COVID-19 affected pressure ulcer patients, large geriatric population in countries such as China and Japan, and surge in patient burden are anticipated to augment the pressure ulcer diagnostics market in Asia Pacific during the forecast period. Rise in awareness about diagnostic tools for pressure ulcers and technological advancements leading to development of imaging techniques, such as fluorescent imaging, thermal imaging, photoacoustic imaging, and sub-epidural moisture scanner for accurate detection of pressure ulcers are expected to propel the market in Asia Pacific during the forecast period.

Pressure Ulcer Diagnostics Market: Major Players

  • Key players operating in the global pressure ulcer diagnostics market are
    • IR-MED
    • Bruin Biometrics LLC
    • Canon Medical Systems Corporation
    • Esaote SPA
    • Fonar Corporation
    • Bruker Corporation
    • FUJIFILM Healthcare Corporation
    • GE Healthcare
    • Arjo
    • Cyberdyne, Inc.
    • MolecuLight, Inc.
  • These players focus on adopting various strategies to launch innovative products to expand their product offerings and to strengthen geographic presence. Amid the COVID-19 pandemic, key players are adopting various strategies to maintain their position and expand the pressure ulcer diagnostics product portfolio across geographies. Technological advancements and expanding footprint of domestic companies in international markets are likely to propel the global pressure ulcer diagnostics market.

Frequently Asked Questions

What is the total market worth of pressure ulcer diagnostics market?

Pressure ulcer diagnostics market is projected to cross US$ 1.49 Bn by 2031

What are the key driving factors for the growth of the pressure ulcer diagnostics market?

Pressure ulcer diagnostics market is driven by rise in awareness about pressure ulcer diagnostic tools & tests, and surge in COVID-19 patients suffering from pressure ulcers & other chronic diseases

Which region is expected to project the highest market share in the global pressure ulcer diagnostics market?

North America accounted for a major share of the global pressure ulcer diagnostics market

Which is the rising prominent segment in the pressure ulcer diagnostics market?

The imaging technique segment accounted for major pressure ulcer diagnostics market share and the trend is projected to continue during the forecast period

Who are the key players in the global pressure ulcer diagnostics market?

Key players operating in the global pressure ulcer diagnostics market are IR-MED, Bruin Biometrics LLC, Canon Medical Systems Corporation, Esaote SPA, Fonar Corporation, Bruker Corporation, FUJIFILM Healthcare Corporation, GE Healthcare

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pressure Ulcer Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Pressure Ulcer Diagnostics Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Disease Prevalence & Incidence Rate globally with key countries

    5.3. Regulatory Scenario by Region/globally

    5.4. Overview of Diagnostic Processes in Wound Management

    5.5. COVID-19 pandemic impact on the Global Pressure Ulcer Diagnostics Market

6. Global Pressure Ulcer Diagnostics Market Analysis and Forecast, by Diagnostic Test

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017–2031

        6.3.1. Imaging Technique

            6.3.1.1. Magnetic Resonance Imaging (MRI)

            6.3.1.2. Computed Tomography (CT) Scan

            6.3.1.3. Fluorescence Imaging

            6.3.1.4. Ultrasound Imaging

            6.3.1.5. Others

        6.3.2. Microbiological Tests

            6.3.2.1. Biopsy

            6.3.2.2. Blood Tests

            6.3.2.3. Others

        6.3.3. Others

    6.4. Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Diagnostic Test

7. Global Pressure Ulcer Diagnostics Market Analysis and Forecast, by Wound, 2017-2031

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

        7.3.1. Stage 1

        7.3.2. Stage 2

        7.3.3. Stage 3

        7.3.4. Stage 4

    7.4. Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Wound

8. Global Pressure Ulcer Diagnostics Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Nursing Homes

        8.3.3. Homecare Settings

        8.3.4. Others

    8.4. Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by End-user

9. Global Pressure Ulcer Diagnostics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Region

10. North America Pressure Ulcer Diagnostics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017–2031

        10.2.1. Imaging Technique

            10.2.1.1. Magnetic Resonance Imaging (MRI)

            10.2.1.2. Computed Tomography (CT) Scan

            10.2.1.3. Fluorescence Imaging

            10.2.1.4. Ultrasound Imaging

            10.2.1.5. Others

        10.2.2. Microbiological Tests

            10.2.2.1. Biopsy

            10.2.2.2. Blood Tests

            10.2.2.3. Others

        10.2.3. Others

    10.3. North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

        10.3.1. Stage 1

        10.3.2. Stage 2

        10.3.3. Stage 3

        10.3.4. Stage 4

    10.4. North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Nursing Homes

        10.4.3. Homecare Settings

        10.4.4. Others

    10.5. North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Pressure Ulcer Diagnostics Market Attractiveness Analysis, 2017–2031

11. Europe Pressure Ulcer Diagnostics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017–2031

        11.2.1. Imaging Technique

            11.2.1.1. Magnetic Resonance Imaging (MRI)

            11.2.1.2. Computed Tomography (CT) Scan

            11.2.1.3. Fluorescence Imaging

            11.2.1.4. Ultrasound Imaging

            11.2.1.5. Others

        11.2.2. Microbiological Tests

            11.2.2.1. Biopsy

            11.2.2.2. Blood Tests

            11.2.2.3. Others

        11.2.3. Others

    11.3. Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

        11.3.1. Stage 1

        11.3.2. Stage 2

        11.3.3. Stage 3

        11.3.4. Stage 4

    11.4. Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Nursing Homes

        11.4.3. Homecare Settings

        11.4.4. Others

    11.5. Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Pressure Ulcer Diagnostics Market Attractiveness Analysis, 2017–2031

12. Asia Pacific Pressure Ulcer Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017–2031

        12.2.1. Imaging Technique

            12.2.1.1. Magnetic Resonance Imaging (MRI)

            12.2.1.2. Computed Tomography (CT) Scan

            12.2.1.3. Fluorescence Imaging

            12.2.1.4. Ultrasound Imaging

            12.2.1.5. Others

        12.2.2. Microbiological Tests

            12.2.2.1. Biopsy

            12.2.2.2. Blood Tests

            12.2.2.3. Others

        12.2.3. Others

    12.3. Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

        12.3.1. Stage 1

        12.3.2. Stage 2

        12.3.3. Stage 3

        12.3.4. Stage 4

    12.4. Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Nursing Homes

        12.4.3. Homecare Settings

        12.4.4. Others

    12.5. Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        12.5.1. Japan

        12.5.2. China

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Pressure Ulcer Diagnostics Market Attractiveness Analysis, 2017–2031

13. Latin America Pressure Ulcer Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017–2031

        13.2.1. Imaging Technique

            13.2.1.1. Magnetic Resonance Imaging (MRI)

            13.2.1.2. Computed Tomography (CT) Scan

            13.2.1.3. Fluorescence Imaging

            13.2.1.4. Ultrasound Imaging

            13.2.1.5. Others

        13.2.2. Microbiological Tests

            13.2.2.1. Biopsy

            13.2.2.2. Blood Tests

            13.2.2.3. Others

        13.2.3. Others

    13.3. Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

        13.3.1. Stage 1

        13.3.2. Stage 2

        13.3.3. Stage 3

        13.3.4. Stage 4

    13.4. Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Nursing Homes

        13.4.3. Homecare Settings

        13.4.4. Others

    13.5. Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Pressure Ulcer Diagnostics Market Attractiveness Analysis, 2017–2031

14. Middle East & Africa Pressure Ulcer Diagnostics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017–2031

        14.2.1. Imaging Technique

            14.2.1.1. Magnetic Resonance Imaging (MRI)

            14.2.1.2. Computed Tomography (CT) Scan

            14.2.1.3. Fluorescence Imaging

            14.2.1.4. Ultrasound Imaging

            14.2.1.5. Others

        14.2.2. Microbiological Tests

            14.2.2.1. Biopsy

            14.2.2.2. Blood Tests

            14.2.2.3. Others

        14.2.3. Others

    14.3. Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

        14.3.1. Stage 1

        14.3.2. Stage 2

        14.3.3. Stage 3

        14.3.4. Stage 4

    14.4. Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

        14.4.1. Hospitals

        14.4.2. Nursing Homes

        14.4.3. Homecare Settings

        14.4.4. Others

    14.5. Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Pressure Ulcer Diagnostics Market Attractiveness Analysis, 2017–2031

15. Competitive Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Company Profiles

        15.3.1. IR-MED

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Product Portfolio

            15.3.1.3. Strategic Overview

            15.3.1.4. SWOT Analysis

        15.3.2. Bruin Biometrics, LLC

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Product Portfolio

            15.3.2.3. Strategic Overview

            15.3.2.4. SWOT Analysis

        15.3.3. Canon Medical Systems Corporation

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Product Portfolio

            15.3.3.3. Financial Overview

            15.3.3.4. Strategic Overview

            15.3.3.5. SWOT Analysis

        15.3.4. Esaote SPA

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Product Portfolio

            15.3.4.3. Strategic Overview

            15.3.4.4. SWOT Analysis

        15.3.5. Fonar Corporation

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Product Portfolio

            15.3.5.3. Financial Overview

            15.3.5.4. Strategic Overview

            15.3.5.5. SWOT Analysis

        15.3.6. Bruker Corporation

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Product Portfolio

            15.3.6.3. Financial Overview

            15.3.6.4. Strategic Overview

            15.3.6.5. SWOT Analysis

        15.3.7. FUJIFILM Healthcare Corporation

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Product Portfolio

            15.3.7.3. Strategic Overview

            15.3.7.4. SWOT Analysis

        15.3.8. GE Healthcare

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Product Portfolio

            15.3.8.3. Financial Overview

            15.3.8.4. Strategic Overview

            15.3.8.5. SWOT Analysis

        15.3.9. Arjo

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Product Portfolio

            15.3.9.3. Financial Overview

            15.3.9.4. Strategic Overview

            15.3.9.5. SWOT Analysis

        15.3.10. CYBERDYNE INC

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Product Portfolio

            15.3.10.3. Financial Overview

            15.3.10.4. Strategic Overview

            15.3.10.5. SWOT Analysis

        15.3.11. MolecuLight Inc.

            15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.11.2. Product Portfolio

            15.3.11.3. Strategic Overview

            15.3.11.4. SWOT Analysis

List of Tables

Table 01: Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Test, 2017–2031

Table 02: Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Imaging Technique, 2017–2031

Table 03: Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Microbiological Tests, 2017–2031

Table 04: Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

Table 05: Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Pressure Ulcer Diagnostics Value Share and Attractiveness Analysis, by Region, 2017–2031

Table 07: North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Tests, 2017–2031

Table 08: North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Imaging Technique, 2017–2031

Table 09: North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Microbiological Tests, 2017–2031

Table 10: North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

Table 11: North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 13: Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Tests, 2017–2031

Table 14: Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Imaging Technique, 2017–2031

Table 15: Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Microbiological Tests, 2017–2031

Table 16: Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

Table 17: Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 19: Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Tests, 2017–2031

Table 20: Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Imaging Technique, 2017–2031

Table 21: Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Microbiological Tests, 2017–2031

Table 22: Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

Table 23: Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 25: Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Tests, 2017–2031

Table 26: Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Imaging Technique, 2017–2031

Table 27: Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Microbiological Tests, 2017–2031

Table 28: Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

Table 29: Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 30: Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 31: Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Tests, 2017–2031

Table 32: Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Imaging Technique, 2017–2031

Table 33: Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Microbiological Tests, 2017–2031

Table 34: Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Wound, 2017–2031

Table 35: Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 36: Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

List of Figures

Figure 01: Global Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Pressure Ulcer Diagnostics Market Value Share, by Diagnostic Test, 2020

Figure 03: Global Pressure Ulcer Diagnostics Market Value Share, by Wound, 2020

Figure 04: Global Pressure Ulcer Diagnostics Value Share, by Region, 2020

Figure 05: Global Pressure Ulcer Diagnostics Value Share, by Region, 2020

Figure 06: Global Pressure Ulcer Diagnostics Market Value Share Analysis, by Diagnostic Test, 2020 and 2031

Figure 07: Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2021–2031

Figure 08: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Imaging Technique, 2017–2031

Figure 09: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Microbiological Tests, 2017–2031

Figure 10: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Others, 2017–2031

Figure 11: Global Pressure Ulcer Diagnostics Market Value Share Analysis, by Wound, 2020 and 2031

Figure 12: Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Wound, 2021–2031

Figure 13: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Stage 1, 2017–2031

Figure 14: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Stage 2, 2017–2031

Figure 15: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Stage 3, 2017–2031

Figure 16: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Stage 4, 2017–2031

Figure 17: Global Pressure Ulcer Diagnostics Market Value Share Analysis, by End-user, 2020 and 2031

Figure 18: Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 19: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 20: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Home Care Settings, 2017–2031

Figure 21: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Nursing Homes, 2017–2031

Figure 22: Global Pressure Ulcer Diagnostics Market Value (US$ Mn), by Others, 2017–2031

Figure 23: Global Pressure Ulcer Diagnostics Market Value Share Analysis, by Region, 2020 and 2031

Figure 24: Global Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Region, 2021–2031

Figure 25: North America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 26: North America Pressure Ulcer Diagnostics Market Value Share Analysis, by Diagnostic Tests, 2020 and 2031

Figure 27: North America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Diagnostic Tests, 2021–2031

Figure 28: North America Pressure Ulcer Diagnostics Market Value Share Analysis, by Wound, 2020 and 2031

Figure 29: North America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Wound, 2021–2031

Figure 30: North America Pressure Ulcer Diagnostics Market Analysis, by End-user, 2020 and 2031

Figure 31: North America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 32: North America Pressure Ulcer Diagnostics Market Analysis, by Country, 2020 and 2031

Figure 33: North America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Country, 2021–2031

Figure 34: Europe Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 35: Europe Pressure Ulcer Diagnostics Market Value Share Analysis, by Diagnostic Tests, 2020 and 2031

Figure 36: Europe Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Diagnostic Tests, 2021–2031

Figure 37: Europe Pressure Ulcer Diagnostics Market Value Share Analysis, by Wound, 2020 and 2031

Figure 38: Europe Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Wound, 2021–2031

Figure 39: Europe Pressure Ulcer Diagnostics Market Analysis, by End-user, 2020 and 2031

Figure 40: Europe Pressure Ulcer Diagnostics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 41: Europe Pressure Ulcer Diagnostics Market Analysis, by Country/Sub-region, 2020 and 2031

Figure 42: Europe Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 43: Asia Pacific Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 44: Asia Pacific Pressure Ulcer Diagnostics Market Value Share Analysis, by Diagnostic Tests, 2020 and 2031

Figure 45: Asia Pacific Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Diagnostic Tests, 2021–2031

Figure 46: Asia Pacific Pressure Ulcer Diagnostics Market Value Share Analysis, by Wound, 2020 and 2031

Figure 47: Asia Pacific Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Wound, 2021–2031

Figure 48: Asia Pacific Pressure Ulcer Diagnostics Market Analysis, by End-user, 2020 and 2031

Figure 49: Asia Pacific Pressure Ulcer Diagnostics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 50: Asia Pacific Pressure Ulcer Diagnostics Market Analysis, by Country/Sub-region, 2020 and 2031

Figure 51: Asia Pacific Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 52: Latin America Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 53: Latin America Pressure Ulcer Diagnostics Market Value Share Analysis, by Diagnostic Tests, 2020 and 2031

Figure 54: Latin America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Diagnostic Tests, 2021–2031

Figure 55: Latin America Pressure Ulcer Diagnostics Market Value Share Analysis, by Wound, 2020 and 2031

Figure 56: Latin America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Wound, 2021–2031

Figure 57: Latin America Pressure Ulcer Diagnostics Market Analysis, by End-user, 2020 and 2031

Figure 58: Latin America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 59: Latin America Pressure Ulcer Diagnostics Market Analysis, by Country/Sub-region, 2020 and 2031

Figure 60: Latin America Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 61: Middle East & Africa Pressure Ulcer Diagnostics Market Value (US$ Mn) Forecast, 2017–2031

Figure 62: Middle East & Africa Pressure Ulcer Diagnostics Market Value Share Analysis, by Diagnostic Tests, 2020 and 2031

Figure 63: Middle East & Africa Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Diagnostic Tests, 2021–2031

Figure 64: Middle East & Africa Pressure Ulcer Diagnostics Market Value Share Analysis, by Wound, 2020 and 2031

Figure 65: Middle East & Africa Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Wound, 2021–2031

Figure 66: Middle East & Africa Pressure Ulcer Diagnostics Market Analysis, by End-user, 2020 and 2031

Figure 67: Middle East & Africa Pressure Ulcer Diagnostics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 68: Middle East & Africa Pressure Ulcer Diagnostics Market Analysis, by Country/Sub-region, 2020 and 2031

Figure 69: Middle East & Africa Pressure Ulcer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved